Three-year outcome of the covered endovascular reconstruction of the aortic bifurcation technique for aortoiliac occlusive disease

Taeymans, Kim; Jebbink, Erik Groot; Holewijn, Suzanne; Martens, Jasper M.; Versluis, Michel; Goverde, Peter; Reijnen, Michel M.P.J.

doi:10.1016/j.jvs.2017.09.015

Cited by 71 publications

(72 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…When we compare these data with the previously mentioned individual-participant meta-analysis on the treatment of kissing stents, it seems that the CERAB group included more complex patients with more critical limb ischemia, more TASC-C and TASC-D lesions and more previously performed reinterventions (Table 2). 6,18 Yet at 24-months, the primary and secondary patency rates were better in the CERAB cohort, suggesting that indeed with CERAB better results could be achieved. A prospective comparative trial on this subject, however, is warranted.…”

Section: Clinical Evidencementioning

confidence: 90%

“…In 2018, Taeymans et al described the mid-term outcome in a series of 130 consecutively electively treated CERAB patients, including the first in human. 18 This was an update from the earlier published one-year data on a smaller cohort. 12 Chimney procedures were excluded from this analysis.…”

Section: Clinical Evidencementioning

confidence: 99%

“…The patency results of both techniques are close (Table 2). 18,22 Nevertheless, the larger profile and the mode of positioning of the AFX Unibody (the device should be pulled onto an occluded or stenosed bifurcation) could render the choice for this option less favorable compared to CERAB. On the other hand, when the infrarenal aorta is dilated to a diameter larger than that can be achieved with the balloon-expandable covered stents, this may be a good alternative, as well as in countries where the large diameter covered stents are not available.…”

Section: Clinical Evidencementioning

confidence: 99%

See 2 more Smart Citations

Update on covered endovascular reconstruction of the aortic bifurcation

Reijnen

2020

Vascular

View full text Add to dashboard Cite

Objective The covered endovascular reconstruction of the aortic bifurcation (CERAB) technique was introduced in 2009 in order to provide an anatomically and physiologically optimal endovascular reconstruction of the aortic bifurcation. Method In the current review, all available evidence on this technique was summarized. Results In vitro studies have shown a more favorable geometry of CERAB compared to kissing stents, leading to better local flow conditions. The results of CERAB are at least as good as those achieved with kissing stents in a more complex group of treated patients. The mid-term patency rates approach those of surgical reconstruction. Initial data show that the technique can also be used in combination with chimney grafts in order to preserve side branches. Conclusion CERAB has proven to be the most optimal endovascular treatment option for aorto-iliac occlusive disease with regard to geometry and flow and is related to promising clinical outcomes. Prospective and comparative trials are necessary to elucidate the most optimal treatment algorithm for patients with aorto-iliac occlusive disease.

show abstract

Section: Clinical Evidencementioning

confidence: 90%

Section: Clinical Evidencementioning

confidence: 99%

Section: Clinical Evidencementioning

confidence: 99%

See 1 more Smart Citation

Update on covered endovascular reconstruction of the aortic bifurcation

Reijnen

2020

Vascular

View full text Add to dashboard Cite

show abstract

“…The covered endovascular reconstruction of the aortic bifurcation technique uses an endovascular approach to place three covered stents in the aortic bifurcation. This technique has demonstrated short-term superiority over the traditional aortobifemoral grafts, highlighting that the first one allows the treatment of patients with more comorbidities and with more complex stenosis 4. The survival rate of patients with aortoiliac occlusive disease is determined by the surgical success, the long-term permeability of the graft, the control of risk factors and cessation of tobacco consumption, among others 5…”

Section: Descriptionmentioning

confidence: 99%

Aortoiliac occlusive disease, a silent syndrome

Rodríguez¹,

Sandoval²

2019

BMJ Case Rep

View full text Add to dashboard Cite

“…In recent years, there has been a marked demographic shift with increasing prevalence of diabetes among patients with SLI and intervention in older, frailer patients 11 38. While there has been little change in recommended medical therapy of PAOD,4 39 new endovascular technologies and improved techniques such as ultradistal bypass and covered endovascular revascularisation of aortic bifurcation allow increasingly aggressive revascularisation strategies 40–42. The Leicester Vascular Institute (based at Glenfield Hospital, University Hospitals of Leicester NHS Trust) is a tertiary referral vascular unit providing all vascular services for Leicestershire and Rutland, compromising a diverse population of approximately 1.1 million.…”

Section: Rationalementioning

confidence: 99%

Leg ischaemia management collaboration (LIMb): study protocol for a prospective cohort study at a single UK centre

et al. 2019

View full text Add to dashboard Cite

IntroductionSevere limb ischaemia (SLI) is the end stage of peripheral arterial occlusive disease where the viability of the limb is threatened. Around 25% of patients with SLI will ultimately require a major lower limb amputation, which has a substantial adverse impact on quality of life. A newly established rapid-access vascular limb salvage clinic and modern revascularisation techniques may reduce amputation rate. The aim of this study was to investigate the 12-month amputation rate in a contemporary cohort of patients and compare this to a historical cohort. Secondary aims are to investigate the use of frailty and cognitive assessments, and cardiac MRI in risk-stratifying patients with SLI undergoing intervention and establish a biobank for future biomarker analyses.Methods and analysisThis single-centre prospective cohort study will recruit patients aged 18–110 years presenting with SLI. Those undergoing intervention will be eligible to undergo additional venepuncture (for biomarker analysis) and/or cardiac MRI. Those aged ≥65 years and undergoing intervention will also be eligible to undergo additional frailty and cognitive assessments. Follow-up will be at 12 and 24 months and subsequently via data linkage with NHS Digital to 10 years postrecruitment. Those undergoing cardiac MRI and/or frailty assessments will receive additional follow-up during the first 12 months to investigate for perioperative myocardial infarction and frailty-related outcomes, respectively. A sample size of 420 patients will be required to detect a 10% reduction in amputation rate in comparison to a similar sized historical cohort, with 90% power and 5% type I error rate. Statistical analysis of this comparison will be by adjusted and unadjusted logistic regression analyses.Ethics and disseminationEthical approval for this study has been granted by the UK National Research Ethics Service (19/LO/0132). Results will be disseminated to participants via scientific meetings, peer-reviewed medical journals and social media.Trial registration numberNCT04027244.

show abstract

Three-year outcome of the covered endovascular reconstruction of the aortic bifurcation technique for aortoiliac occlusive disease

Abstract: The CERAB technique is a safe and feasible technique for the treatment of extensive AIOD with good 3-year results regarding patency and clinical improvement.

Cited by 71 publications

References 28 publications

Update on covered endovascular reconstruction of the aortic bifurcation

Update on covered endovascular reconstruction of the aortic bifurcation

Aortoiliac occlusive disease, a silent syndrome

Leg ischaemia management collaboration (LIMb): study protocol for a prospective cohort study at a single UK centre

Contact Info

Product

Resources

About